- Home
- MGYR vs TCRX Comparison
MGYR vs TCRX Comparison
Compare MGYR & TCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGYR
- TCRX
- Stock Information
- Founded
- MGYR 1922
- TCRX 2018
- Country
- MGYR United States
- TCRX United States
- Employees
- MGYR N/A
- TCRX N/A
- Industry
- MGYR Savings Institutions
- TCRX Biotechnology: Pharmaceutical Preparations
- Sector
- MGYR Finance
- TCRX Health Care
- Exchange
- MGYR Nasdaq
- TCRX Nasdaq
- Market Cap
- MGYR 94.1M
- TCRX 98.5M
- IPO Year
- MGYR 2006
- TCRX 2021
- Fundamental
- Price
- MGYR $13.98
- TCRX $1.35
- Analyst Decision
- MGYR
- TCRX Strong Buy
- Analyst Count
- MGYR 0
- TCRX 6
- Target Price
- MGYR N/A
- TCRX $9.83
- AVG Volume (30 Days)
- MGYR 2.9K
- TCRX 437.3K
- Earning Date
- MGYR 04-22-2025
- TCRX 03-05-2025
- Dividend Yield
- MGYR 1.79%
- TCRX N/A
- EPS Growth
- MGYR 10.61
- TCRX N/A
- EPS
- MGYR 1.30
- TCRX N/A
- Revenue
- MGYR $32,424,000.00
- TCRX $2,816,000.00
- Revenue This Year
- MGYR N/A
- TCRX $32.21
- Revenue Next Year
- MGYR N/A
- TCRX $118.35
- P/E Ratio
- MGYR $10.81
- TCRX N/A
- Revenue Growth
- MGYR 7.24
- TCRX N/A
- 52 Week Low
- MGYR $10.66
- TCRX $1.34
- 52 Week High
- MGYR $14.90
- TCRX $9.69
- Technical
- Relative Strength Index (RSI)
- MGYR 40.34
- TCRX 29.10
- Support Level
- MGYR $14.14
- TCRX $1.44
- Resistance Level
- MGYR $14.09
- TCRX $1.76
- Average True Range (ATR)
- MGYR 0.24
- TCRX 0.17
- MACD
- MGYR -0.04
- TCRX -0.01
- Stochastic Oscillator
- MGYR 7.89
- TCRX 1.82
About MGYR Magyar Bancorp Inc.
Magyar Bancorp Inc is a mid-tier stock holding company. The Company offers a full array of commercial and retail financial services, including the taking of time, savings and demand deposits; the making of commercial, consumer and home equity loans; and the provision of other financial services. The business consists of getting retail deposits from the general public in the areas surrounding the main office in New Brunswick, New Jersey and branch offices located in Middlesex and Somerset Counties, New Jersey, and investing those deposits, together with funds generated from operations and wholesale funding, in residential mortgage loans, home equity loans, home equity lines of credit, commercial real estate loans, commercial business loans, Small Business Administration loans.
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.